| Print
GlycoMimetics (GLYC)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.
Address
9708 Medical Center Drive
Suite 250
Rockville
MD
USA
20850
Telephone
+1 240 2431201
Forecast key dates
| Name | Key Date |
|---|---|
| GlycoMimetics Inc Annual Report for 2025 | 2026-02-13T00:00:00 |
| GlycoMimetics Inc Third Quarter Earnings Results for 2025 | 2025-11-13T00:00:00 |
| GlycoMimetics Inc Second Quarter Earnings Results for 2025 | 2025-08-08T00:00:00 |
| GlycoMimetics Inc Second Quarter Earnings Conference Call for 2025 | 2025-08-08T00:00:00 |
| GlycoMimetics Inc First Quarter Earnings Conference Call for 2025 | 2025-05-09T08:30:00 |
| GlycoMimetics Inc First Quarter Earnings Results for 2025 | 2025-05-09T00:00:00 |
| GlycoMimetics Inc Annual General Meeting for 2025 | 2025-05-01T09:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| GlycoMimetics Inc First Quarter Earnings Conference Call for 2025 | 2025-05-09T08:30:00 |
| GlycoMimetics Inc First Quarter Earnings Results for 2025 | 2025-05-09T00:00:00 |
| GlycoMimetics Inc Annual General Meeting for 2025 | 2025-05-01T09:00:00 |
| GlycoMimetics Inc Annual Report for 2024 | 2025-02-13T00:00:00 |
| GlycoMimetics Inc Third Quarter Earnings Results for 2024 | 2024-11-13T00:00:00 |
| GlycoMimetics Enters Into Acquisition Agreement With Crescent Biopharma | 2024-10-29T08:00:00 |
| GlycoMimetics Inc Second Quarter Earnings Results for 2024 | 2024-08-08T00:00:00 |
| GlycoMimetics Inc Second Quarter Earnings Conference Call for 2024 | 2024-08-08T00:00:00 |
| GlycoMimetics KOL Event | 2024-06-04T08:30:00 |
| GlycoMimetics Inc First Quarter Earnings Conference Call for 2024 | 2024-05-09T08:30:00 |
| GlycoMimetics Inc First Quarter Earnings Result for 2024 | 2024-05-09T00:00:00 |
| GlycoMimetics Corporate Update Call | 2024-05-06T08:30:00 |
| GlycoMimetics Inc Annual General Meeting for 2024 | 2024-05-01T09:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.